128 related articles for article (PubMed ID: 19205515)
21. Mutations in endoglin and in activin receptor-like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia.
Brusgaard K; Kjeldsen AD; Poulsen L; Moss H; Vase P; Rasmussen K; Kruse TA; Hørder M
Clin Genet; 2004 Dec; 66(6):556-61. PubMed ID: 15521985
[TBL] [Abstract][Full Text] [Related]
22. Hereditary hemorrhagic telangiectasia. Genetics, pathogenesis, clinical manifestation and management.
Stuhrmann M; El-Harith el-HA
Saudi Med J; 2007 Jan; 28(1):11-21. PubMed ID: 17206283
[TBL] [Abstract][Full Text] [Related]
23. Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia.
Fontalba A; Fernandez-L A; García-Alegria E; Albiñana V; Garrido-Martin EM; Blanco FJ; Zarrabeitia R; Perez-Molino A; Bernabeu-Herrero ME; Ojeda ML; Fernandez-Luna JL; Bernabeu C; Botella LM
BMC Med Genet; 2008 Aug; 9():75. PubMed ID: 18673552
[TBL] [Abstract][Full Text] [Related]
24. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan.
Dakeishi M; Shioya T; Wada Y; Shindo T; Otaka K; Manabe M; Nozaki J; Inoue S; Koizumi A
Hum Mutat; 2002 Feb; 19(2):140-8. PubMed ID: 11793473
[TBL] [Abstract][Full Text] [Related]
25. Detection of a significant association between mutations in the ACVRL1 gene and hepatic involvement in German patients with hereditary haemorrhagic telangiectasia.
Brakensiek K; Frye-Boukhriss H; Mälzer M; Abramowicz M; Bahr MJ; von Beckerath N; Bergmann C; Caselitz M; Holinski-Feder E; Muschke P; Oexle K; Strobl-Wildemann G; Wolff G; El-Harith EA; Stuhrmann M
Clin Genet; 2008 Aug; 74(2):171-7. PubMed ID: 18498373
[TBL] [Abstract][Full Text] [Related]
26. Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations.
Bayrak-Toydemir P; McDonald J; Markewitz B; Lewin S; Miller F; Chou LS; Gedge F; Tang W; Coon H; Mao R
Am J Med Genet A; 2006 Mar; 140(5):463-70. PubMed ID: 16470787
[TBL] [Abstract][Full Text] [Related]
27. Mutation analysis in hereditary haemorrhagic telangiectasia in Germany reveals 11 novel ENG and 12 novel ACVRL1/ALK1 mutations.
Wehner LE; Folz BJ; Argyriou L; Twelkemeyer S; Teske U; Geisthoff UW; Werner JA; Engel W; Nayernia K
Clin Genet; 2006 Mar; 69(3):239-45. PubMed ID: 16542389
[TBL] [Abstract][Full Text] [Related]
28. High frequency of ENG and ALK1/ACVRL1 mutations in German HHT patients.
Schulte C; Geisthoff U; Lux A; Kupka S; Zenner HP; Blin N; Pfister M
Hum Mutat; 2005 Jun; 25(6):595. PubMed ID: 15880681
[TBL] [Abstract][Full Text] [Related]
29. Genotype-phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia.
Letteboer TG; Mager HJ; Snijder RJ; Lindhout D; Ploos van Amstel HK; Zanen P; Westermann KJ
Am J Med Genet A; 2008 Nov; 146A(21):2733-9. PubMed ID: 18831062
[TBL] [Abstract][Full Text] [Related]
30. Hereditary hemorrhagic telangiectasia: two distinct ENG deletions in one family.
Wooderchak W; Gedge F; McDonald M; Krautscheid P; Wang X; Malkiewicz J; Bukjiok CJ; Lewis T; Bayrak-Toydemir P
Clin Genet; 2010 Nov; 78(5):484-9. PubMed ID: 20412114
[TBL] [Abstract][Full Text] [Related]
31. Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France.
Lesca G; Plauchu H; Coulet F; Lefebvre S; Plessis G; Odent S; Rivière S; Leheup B; Goizet C; Carette MF; Cordier JF; Pinson S; Soubrier F; Calender A; Giraud S;
Hum Mutat; 2004 Apr; 23(4):289-99. PubMed ID: 15024723
[TBL] [Abstract][Full Text] [Related]
32. Association of hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome) and malignant melanoma in two patients.
Kluger N; Riviére S; Coupier I; Bessis D; Guillot B
Melanoma Res; 2007 Jun; 17(3):201-3. PubMed ID: 17505266
[TBL] [Abstract][Full Text] [Related]
33. Hereditary Haemorrhagic Telangiectasia (HHT): genetic and molecular aspects.
Lenato GM; Guanti G
Curr Pharm Des; 2006; 12(10):1173-93. PubMed ID: 16611099
[TBL] [Abstract][Full Text] [Related]
34. Mosaic ACVRL1 and ENG mutations in hereditary haemorrhagic telangiectasia patients.
Best DH; Vaughn C; McDonald J; Damjanovich K; Runo JR; Chibuk JM; Bayrak-Toydemir P
J Med Genet; 2011 May; 48(5):358-60. PubMed ID: 21378382
[TBL] [Abstract][Full Text] [Related]
35. The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: a cross-sectional study.
Dheyauldeen S; Abdelnoor M; Bachmann-Harildstad G
Am J Rhinol Allergy; 2011; 25(4):214-8. PubMed ID: 21819756
[TBL] [Abstract][Full Text] [Related]
36. Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-β1 signaling in endothelial cells.
Albiñana V; Sanz-Rodríguez F; Recio-Poveda L; Bernabéu C; Botella LM
Mol Pharmacol; 2011 May; 79(5):833-43. PubMed ID: 21310938
[TBL] [Abstract][Full Text] [Related]
37. Novel mutations and polymorphisms in genes causing hereditary hemorrhagic telangiectasia.
Abdalla SA; Cymerman U; Rushlow D; Chen N; Stoeber GP; Lemire EG; Letarte M
Hum Mutat; 2005 Mar; 25(3):320-1. PubMed ID: 15712271
[TBL] [Abstract][Full Text] [Related]
38. A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1.
Wallace GM; Shovlin CL
Thorax; 2000 Aug; 55(8):685-90. PubMed ID: 10899246
[TBL] [Abstract][Full Text] [Related]
39. Molecular defects in rare bleeding disorders: hereditary haemorrhagic telangiectasia.
Shovlin CL
Thromb Haemost; 1997 Jul; 78(1):145-50. PubMed ID: 9198145
[TBL] [Abstract][Full Text] [Related]
40. Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT).
Ojeda-Fernandez L; Barrios L; Rodriguez-Barbero A; Recio-Poveda L; Bernabeu C; Botella LM
Clin Chim Acta; 2010 Apr; 411(7-8):494-9. PubMed ID: 20067780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
